Filing Details
- Accession Number:
- 0001127602-17-031437
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-07 12:32:48
- Reporting Period:
- 2017-11-03
- Accepted Time:
- 2017-11-07 12:32:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238337 | A Luke Pomilio | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | Evp, Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-03 | 10,020 | $39.87 | 44,472 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-03 | 10,020 | $53.57 | 34,452 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-11-03 | 8,000 | $16.46 | 42,452 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-03 | 5,277 | $53.37 | 37,175 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-11-03 | 10,000 | $19.26 | 47,175 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-03 | 6,854 | $53.37 | 40,321 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-11-03 | 10,000 | $27.63 | 50,321 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-03 | 7,626 | $53.37 | 42,695 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-11-03 | 10,000 | $26.09 | 52,695 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-03 | 7,484 | $53.37 | 45,211 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-11-03 | 9,600 | $32.93 | 54,811 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-03 | 7,790 | $53.37 | 47,021 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-11-03 | 4,680 | $44.90 | 51,701 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-03 | 4,315 | $53.37 | 47,386 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2017-11-03 | 10,020 | $0.00 | 10,020 | $39.87 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2017-11-03 | 8,000 | $0.00 | 8,000 | $16.46 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2017-11-03 | 10,000 | $0.00 | 10,000 | $19.26 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2017-11-03 | 10,000 | $0.00 | 10,000 | $27.63 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2017-11-03 | 10,000 | $0.00 | 10,000 | $26.09 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2017-11-03 | 9,600 | $0.00 | 9,600 | $32.93 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2017-11-03 | 4,680 | $0.00 | 4,680 | $44.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,080 | 2026-03-01 | No | 4 | M | Direct | |
| 0 | 2019-06-01 | No | 4 | M | Direct | |
| 0 | 2020-06-01 | No | 4 | M | Direct | |
| 0 | 2021-06-01 | No | 4 | M | Direct | |
| 0 | 2022-06-01 | No | 4 | M | Direct | |
| 2,400 | 2023-06-01 | No | 4 | M | Direct | |
| 3,120 | 2024-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.55 to $53.595. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder."
- The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Billionaire Hedge Funds
